TIAP - Toronto Innovation Acceleration Partners’ Post

Our coaching sessions are going great! I can't wait to see the final presentations with you. Join us over Zoom even if you are not in Chicago! #angelinvesting #investors Perkins Coie LLP

Fully agree! Basics - do you have a strategy in place and does everyone know what it is? When selling services, how is your sales & operational planning set up? Are they talking to one another? Do you know your levers? How have you built flexible capacity? Do you have a system in place where you know all the activities happening and where you can prioritize? Do you have the right people and architecture in place? Do you have financial discipline? I’ve learned these lessons personally throughout my career. I see some companies that always feel like chaos and I wonder if it’s just accepted…it’s not a pleasant life for it’s people and it’s expensive.

Fundraising and Raising Equity Capital - Private Equity/Funding of Life Science Startups and High-Growth Companies Raising equity capital in an investor-friendly market In a recent webinar, I hosted Aaron Fisher, former Vice President, BroadOak Capital Partners, to discuss life science startups and high-growth companies from a private equity perspective. In this segment, Aaron discusses fundraising and raising equity capital. For the full webinar, click the link in the comments. I'm committed to continuing this complimentary series and covering a variety of topics for leaders in the Molecular Diagnostics and Life Science Tools domains. If you would like to stay informed on future webinars, please send me a message with your contact information. #startups #lifesciences #lifesciencetools #biopharma 

Top 5 VC deals from Tuesday's Espresso Memo ☀: -- Want to be become smarter about the UK and European startup scene? Join 200 of the UK's and Europe's top founders, investors & tech enthusiasts and get the full version of the Espresso Memo in your your inbox every morning, for free. ☀️ Link in the comments 👇 -- 1. Genomes.io, a London-based biotech focused on the safe, private, and auditable monetisation of genomic data, received $20m from GEM Digital Limited 2. Qualifyze, a Frankfurt-based compliance company, raised a $12m from HV Capital and Rheingau Founders, and new investors HarbourVest Partners and H14 3. Kamma, a London-based property data and analytics company, raised £3.6m in funding. The round was led by Clean Growth Fund with participation from TriplePoint Capital and Pi Labs, plus The Conduit EIS Impact Fund and Kiilto Ventures 4. Mysthera Therapeutics, a Basel-based company developing oral therapeutics to treat complex autoimmune diseases, raised $3.5m in Seed funding. Forty51 Ventures made the investment 5. Remora Robotics, a Stavanger-based aquaculture robotics company, raised €2.5m from Grieg Kapital and Momentum #venturecapital

Massive congrats to founders Hans Henrik H. Knudsen, Nikolaj Thomas Zinner, Allan Grønlund and rest of Kvantify for raising this €10m seed round 👏 Plus, proud of the Dreamcraft Ventures gang who led alongside amazing co-investors Lundbeckfonden / Lundbeck Foundation and Redstone WITH strong backing from existing investors 2degrees (big shout-out Clive Eley, Soren Wiberg Holm and Mikkel Bulow-Lehnsby for playing the key roles you did), 2xN, Export and Investment Fund of Denmark, many others. 🏗️ The Copenhagen-based quantum co's first attack vector is drug discovery, where their suite accelerates the discovery process by improving efficiency and accuracy of in-silico simulation testing, enabling the rapid creation and evaluation of different potential drugs. Their approach yields an order-of-magnitude delta for drug development and addresses major causes of failure💡 The round provides the team with the resources and strategic partnerships needed to accelerate development and growth 🚀 Let’s make some noise for the Kvantify team 📣👏 Read more in Børsen, Tech.eu, Silicon Canals - European Technology News and more - find the links in the comments 👇 #venturecapital #B2B #startup #quantum

What are the Most Active VC Funds in Health-Tech in Europe? 💊 Despite shifts in funding and deal volume in 2023, the European health technology scene is buzzing with activity. Investors are placing their bets on startups revolutionizing treatment approaches and tackling nonclinical workflow challenges. Let's shine a spotlight on the Top 25 that shaped early-stage health-tech deals in Europe: https://lnkd.in/gPEuV5Ju

Such great news for the biotech and life sciences start-up space in Europe! From Goldman Sachs' first Life Sciences VC Fund to Earlybird's Health Tech fund, these achievements demonstrate the industry's recognition of the importance of private companies in the health tech sector, which can help address the shortcomings of the public healthcare system and drive innovation. I am more than thrilled to witness the potential impact these start-ups can have in revolutionizing the healthcare industry! E11evate #venturecapital #venturestudio #healthtech #biotech #medtech

What better way to kick off 2024 than by building knowledge to help elevate your startup?   Signs point towards this being another challenging year for the industry - with an uncertain funding landscape and the effects of inflation likely to make talent attraction and retention trickier. To best prepare for what 2024 holds, startups need to understand the landscape and focus on building high-performing teams.   This January, stay ahead of the curve by joining our panel of industry experts for a webinar where they’ll share their predictions for year ahead. As well as giving you actionable advice on how to attract and retain top talent in this fast-moving economic landscape, they’ll also be taking your questions.   👉Secure your spot now: https://rb.gy/y2up4l 📅 17 January ⌚ 13:00 - 14:30 GMT   The panel will be chaired by Emma Plowman, our Talent Director, who will be joined by our CEO, Jason Mellad, Sam Ingram from Northreach, Paula Rogers-Brown from The Milner Therapeutics Institute, and Emma Longland from Venner Shipley.   #StartUps #Funding #Investment #TalentAttraction #TalentRetention #Webinar #FreeEvent #Event

#top50familyoffices the strüngmann twins' investment in BioNTech SE proves the transformative power of "old money" for the startup ecosystem. their investment not only accelerated BioNTech's COVID-19 vaccine but showcases the pivotal role which family offices can play, in bridging the gap from research to startups which become European tech champions. if you are interested in the topic, I can highly recommend Mark Boeschen‘s article about the 50 largest #familyoffices in Germany (link in the comments). If you are a founder with ambitions to build another European tech champion, reach out to us at DTCF | DeepTech & Climate Fonds